ReoPro (abciximab): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Reopro 2mg/ml solution for injection or infusion.

ReoPro is indicated in adults as an adjunct to heparin and acetylsalicylic acid for:

• Percutaneous coronary intervention

The prevention of ischemic cardiac complications in patients undergoing percutaneous coronary intervention (balloon angioplasty, atherectomy and stent)

• Unstable angina

The short-term (1-month) reduction of the risk of myocardial infarction, in patients with unstable angina, not responding to full conventional therapy who have been scheduled for percutaneous coronary intervention.


Route of administration: Injectable
Molecule: abciximab

Patients' opinions on ReoPro

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.